Elanco Files for Formal EU Review of Bayer Animal Health Deal
April 14 2020 - 11:47AM
Dow Jones News
By Colin Kellaher
Elanco Animal Health Inc. on Tuesday said it has formally
submitted its planned $7.6 billion acquisition of Bayer AG's
animal-health business to the European Commission for regulatory
approval.
The Greenfield, Ind., animal-health company said the filing of
Form CO notification triggers the start of the statutory review
period, adding that the commission now has until June 8 to make its
decision.
Elanco previously announced planned divestitures of businesses
with revenue of $120 million to $140 million in a bid to gain
regulatory blessing for the deal.
The company has also fully secured financing to complete the
transaction, which it said remains on track with its original
mid-2020 closing plans.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 14, 2020 11:32 ET (15:32 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
